PitchSend

InspireMD Company Overview

The potential paradigm shift with CGuardTM InspireMD Carotid procedures today are primarily surgical Carotid procedures tomorrow could be mostly minimally invasive with CGuard™ 80% of Market ■CEA CAS MicroNet™ covered stents could become the Gold Standard 20% of Market □ CAS 100% of addressable - market $1.0 Billion 2.2M diagnosed with carotid artery disease . • 2017: 600,000 patients with high grade carotid stenosis (HGCS) require interventions for CAD At present, -80% are surgically treated with carotid endarderectomy (CEA) At a price of $1,650 per stent, the addressable market is more than $1 billion 2017 Health Research International Market Report 7

View entire presentation